European Committee Takes a Second Look at Alzheimer's Drug
Hosted on MSN3h
Structural analysis shows Alzheimer's disease mutation produces 'cottonwool' structures in the brainAn international collaboration led by RIKEN researchers has discovered how unusual spherical structures form in the brains of ...
Biogen’s stock rose 1% Thursday, after Europe’s pharmaceutical regulator issued a positive opinion on the Alzheimer’s disease ...
University of Washington-led research, published in 2023, discovered microglia in the brains of people with Alzheimer's ...
As we count down toward the December readout of Cassava Sciences’ simufilam Phase 3 clinical trial in Alzheimer’s disease ...
Researchers discovered that the enzyme TYK2 alters the tau protein, promoting its accumulation in the brain, a process linked ...
The AD risk factors/hits include high exposure to traffic-related air pollution (TRAP) and infections, as well as factors ...
Because November is Diabetes and Alzheimer’s awareness month, we are learning about the link between brain health and insulin ...
The European Union's drugs regulator on Thursday said it recommends approval of Eisai and Biogen's Leqembi in patients with ...
Money Talks News on MSN3h
Healthy Obesity Linked to Lower Alzheimer's Risk, Study RevealsA recent study found that relatively healthy obesity may reduce the risk of developing Alzheimer's disease.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback